RecruitingNot ApplicableNCT04172753
Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)
Sponsor
University Hospital Tuebingen
Enrollment
472 participants
Start Date
May 9, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- existing indication for radiation therapy
- minimum age 18 years, no upper age limit
- capacity for consent
- Informed consent
Exclusion Criteria2
- contraindication for MRI (claustrophobia, metallic implants not applicable for MRI
- pregnancy
Interventions
RADIATIONRadiotherapy on the MR-Linac
Radiotherapy is performed on the 1.5 T MR Linac
DIAGNOSTIC_TESTImaging on the MR Linac
Only imaging performed on the MR Linac
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04172753
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location